by Shana Cristoferi | Oct 23, 2019 | Densitas Inc., News
See original Entrevestor article here Halifax-based Densitas Inc. whose software helps assess the density of breasts during mammograms, announced this week its densitas densityai software will soon be available on the Nuance AI Marketplace. In a statement, Densitas...
by Shana Cristoferi | Sep 23, 2019 | Densitas Inc., News
See original news release here Announcing our densitas densityai™ software will be deployed in up to 24 clinics throughout Germany as part of a procurement for a major breast cancer screening trial. Our software will be used to provide breast density measurements at...
by Shana Cristoferi | Sep 13, 2019 | News
Read original article here IMV Inc., the Dartmouth company developing a delivery platform for immunotherapy drugs, is entering a critical phase of its 16-year history as it will soon learn the results of key Phase 2 clinical trials. The company is conducting a range...
by Shana Cristoferi | Sep 11, 2019 | News
Read original news release here — Transaction continues to advance Mallinckrodt’s strategic focus on branded biopharmaceuticals by monetizing a non-core business — — H.I.G. Capital to support BioVectra leadership and its attractive growth plan...
by Shana Cristoferi | Sep 5, 2019 | IMV Inc., News
Read original article here September 4, 2019 at 7:05 AM EDT DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–Sep. 4, 2019– IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage immuno-oncology company, today announced a collaboration with The Wistar Institute and...